Man Group
CGON icon

Man Group’s CG Oncology CGON Stock Holding History

Man Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Buy
+51,849
New +$3.39M 0.01% 1276
2025
Q3 		– Sell
-8,619
Closed -$224K – 2243
2025
Q2 		$224K Buy
+8,619
New +$208K ﹤0.01% 2041

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Man Group's CGON Position: Q2 2026 in Review

Man Group opened a new position in CG Oncology (CGON) in Q2 2026: 51,849 shares worth $3.68M. The stake represents 0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Man Group previously reported a position in CGON as recently as Q2 2025.

Man Group first reported a position in CGON in Q2 2025 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Man Group held 51,849 shares of CG Oncology worth $3.68M as of Q2 2026.
  • CG Oncology was a new Man Group position in Q2 2026.
  • CG Oncology made up 0.01% of Man Group's portfolio in Q2 2026, its #1276 holding.
  • Man Group first reported a position in CG Oncology in Q2 2025 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.